Trial Profile
Phase II, multicentre, randomised, double blind, placebo conntrolled pilot study to determine proof of efficacy, safety, tolerablility and pharmacokinetics of intravesical PSD597 in the symptomatic management of interstitial cystitis/painful bladder syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2021
Price :
$35
*
At a glance
- Drugs Lidocaine (Primary) ; Sodium bicarbonate
- Indications Bladder disorders; Interstitial cystitis; Pain
- Focus Proof of concept; Therapeutic Use
- Sponsors Plethora Solutions
- 10 Nov 2006 New trial record.